$GOSS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Gossamer Bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Gossamer Bio, Inc.. Get notifications about new insider transactions in Gossamer Bio, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 10 2021 | GOSS | Gossamer Bio, Inc. | Burow Kristina | Director | Option Exercise | A | 8.97 | 23,500 | 210,795 | 23,500 | |
May 05 2021 | GOSS | Gossamer Bio, Inc. | Carter Laura | Chief Scientific Of ... | Option Exercise | A | 8.70 | 31,750 | 276,225 | 31,750 | |
May 05 2021 | GOSS | Gossamer Bio, Inc. | Carter Laura | Chief Scientific Of ... | Grant | A | 0.00 | 10,820 | 0 | 72,683 | 61.9 K to 72.7 K (+17.49 %) |
Apr 20 2021 | GOSS | Gossamer Bio, Inc. | Peterson Caryn | EVP, Regulatory Aff ... | Option Exercise | A | 8.49 | 31,750 | 269,558 | 31,750 | |
Apr 20 2021 | GOSS | Gossamer Bio, Inc. | Peterson Caryn | EVP, Regulatory Aff ... | Grant | A | 0.00 | 10,820 | 0 | 74,828 | 64 K to 74.8 K (+16.90 %) |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | President & CEO | Option Exercise | A | 9.79 | 325,000 | 3,181,750 | 325,000 | |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | President & CEO | Grant | A | 0.00 | 162,500 | 0 | 162,500 | 0 to 162.5 K |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Option Exercise | A | 9.79 | 90,000 | 881,100 | 90,000 | |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Option Exercise | A | 9.79 | 90,000 | 881,100 | 90,000 | |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Grant | A | 0.00 | 45,000 | 0 | 115,379 | 70.4 K to 115.4 K (+63.94 %) |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Grant | A | 0.00 | 45,000 | 0 | 115,379 | 70.4 K to 115.4 K (+63.94 %) |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Christian Waage | EVP & General Couns ... | Option Exercise | A | 9.79 | 90,000 | 881,100 | 90,000 | |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Christian Waage | EVP & General Couns ... | Grant | A | 0.00 | 45,000 | 0 | 593,689 | 548.7 K to 593.7 K (+8.20 %) |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Christian Waage | EVP & General Couns ... | Option Exercise | A | 9.79 | 90,000 | 881,100 | 90,000 | |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Christian Waage | EVP & General Couns ... | Grant | A | 0.00 | 45,000 | 0 | 593,689 | 548.7 K to 593.7 K (+8.20 %) |
Jun 23 2020 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Buy | P | 12.96 | 2,000 | 25,922 | 4,121 | 2.1 K to 4.1 K (+94.30 %) |
Jun 18 2020 | GOSS | Gossamer Bio, Inc. | GALA RENEE D | Director | Option Exercise | A | 12.10 | 23,500 | 284,350 | 23,500 | |
Jun 18 2020 | GOSS | Gossamer Bio, Inc. | Daniel Thomas O | Director | Option Exercise | A | 12.10 | 23,500 | 284,350 | 23,500 | |
Jun 18 2020 | GOSS | Gossamer Bio, Inc. | Cox Russell J. | Director | Option Exercise | A | 12.10 | 23,500 | 284,350 | 23,500 | |
Jun 18 2020 | GOSS | Gossamer Bio, Inc. | Burow Kristina | Director | Option Exercise | A | 12.10 | 23,500 | 284,350 | 23,500 | |
Jun 18 2020 | GOSS | Gossamer Bio, Inc. | Bilenker Joshua H. | Director | Option Exercise | A | 12.10 | 23,500 | 284,350 | 23,500 | |
Jun 18 2020 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Director | Option Exercise | A | 12.10 | 47,000 | 568,700 | 47,000 | |
Feb 19 2020 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Option Exercise | A | 14.55 | 71,500 | 1,040,325 | 71,500 | |
Feb 19 2020 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Grant | A | 0.00 | 46,500 | 0 | 46,500 | 0 to 46.5 K |
Feb 19 2020 | GOSS | Gossamer Bio, Inc. | Salter-Cid Luisa | Chief Scientific Of ... | Option Exercise | A | 14.55 | 71,500 | 1,040,325 | 71,500 | |
Feb 19 2020 | GOSS | Gossamer Bio, Inc. | Salter-Cid Luisa | Chief Scientific Of ... | Grant | A | 0.00 | 46,500 | 0 | 166,556 | 120.1 K to 166.6 K (+38.73 %) |
Feb 19 2020 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Option Exercise | A | 14.55 | 292,000 | 4,248,600 | 292,000 | |
Feb 19 2020 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Grant | A | 0.00 | 189,500 | 0 | 189,500 | 0 to 189.5 K |
Jan 02 2020 | GOSS | Gossamer Bio, Inc. | Salter-Cid Luisa | Chief Scientific Of ... | Gift | G | 0.00 | 4,000 | 0 | 120,056 | 124.1 K to 120.1 K (-3.22 %) |
Dec 31 2019 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Option Exercise | M | 10.71 | 40,000 | 428,400 | 439,317 | |
Dec 31 2019 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Option Exercise | M | 10.71 | 1,994 | 21,356 | 479,317 | |
Dec 31 2019 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Sell | S | 15.00 | 40,000 | 600,004 | 0 | 40 K to 0 (-100.00 %) |
Dec 31 2019 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Buy | M | 10.71 | 40,000 | 428,400 | 40,000 | 0 to 40 K |
Dec 31 2019 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Sell | S | 15.81 | 1,994 | 31,534 | 0 | 2 K to 0 (-100.00 %) |
Dec 31 2019 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Buy | M | 10.71 | 1,994 | 21,356 | 1,994 | 0 to 2 K |
Sep 27 2019 | GOSS | Gossamer Bio, Inc. | Christian Waage | EVP & General Couns ... | Buy | P | 16.65 | 1,000 | 16,654 | 4,454 | 3.5 K to 4.5 K (+28.95 %) |
Sep 27 2019 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Director | Buy | P | 16.80 | 10,000 | 167,980 | 3,382,109 | 3.4 M to 3.4 M (+0.30 %) |
Sep 27 2019 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Buy | P | 16.80 | 10,000 | 167,980 | 4,048,242 | 4 M to 4 M (+0.25 %) |
Sep 26 2019 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Buy | P | 16.78 | 1,121 | 18,810 | 2,121 | 1,000 to 2.1 K (+112.10 %) |
Sep 23 2019 | GOSS | Gossamer Bio, Inc. | Omega Fund V, L.P. | 10% Owner | Sell | S | 21.96 | 183,607 | 4,032,561 | 6,553,416 | 6.7 M to 6.6 M (-2.73 %) |
Sep 18 2019 | GOSS | Gossamer Bio, Inc. | Omega Fund V, L.P. | 10% Owner | Sell | S | 21.88 | 45,600 | 997,637 | 6,737,023 | 6.8 M to 6.7 M (-0.67 %) |
Sep 18 2019 | GOSS | Gossamer Bio, Inc. | Omega Fund V, L.P. | 10% Owner | Sell | S | 21.62 | 23,400 | 505,791 | 6,782,623 | 6.8 M to 6.8 M (-0.34 %) |
Sep 18 2019 | GOSS | Gossamer Bio, Inc. | Omega Fund V, L.P. | 10% Owner | Sell | S | 21.52 | 13,213 | 284,331 | 6,806,023 | 6.8 M to 6.8 M (-0.19 %) |
Sep 12 2019 | GOSS | Gossamer Bio, Inc. | Omega Fund V, L.P. | 10% Owner | Sell | S | 21.31 | 80,403 | 1,713,629 | 6,819,236 | 6.9 M to 6.8 M (-1.17 %) |
Sep 12 2019 | GOSS | Gossamer Bio, Inc. | Omega Fund V, L.P. | 10% Owner | Sell | S | 21.00 | 32,373 | 679,865 | 6,899,639 | 6.9 M to 6.9 M (-0.47 %) |
Sep 09 2019 | GOSS | Gossamer Bio, Inc. | Omega Fund V, L.P. | 10% Owner | Sell | S | 21.51 | 8,700 | 187,103 | 6,932,012 | 6.9 M to 6.9 M (-0.13 %) |
Sep 09 2019 | GOSS | Gossamer Bio, Inc. | Omega Fund V, L.P. | 10% Owner | Sell | S | 21.60 | 12,704 | 274,434 | 6,940,712 | 7 M to 6.9 M (-0.18 %) |
Aug 29 2019 | GOSS | Gossamer Bio, Inc. | Salter-Cid Luisa | Chief Scientific Of ... | Sell | S | 20.09 | 26,252 | 527,319 | 124,056 | 150.3 K to 124.1 K (-17.47 %) |
Aug 29 2019 | GOSS | Gossamer Bio, Inc. | Salter-Cid Luisa | Chief Scientific Of ... | Sell | S | 19.65 | 23,748 | 466,724 | 150,308 | 174.1 K to 150.3 K (-13.64 %) |
Jun 11 2019 | GOSS | Gossamer Bio, Inc. | Stampacchia Otello | Director | Option Exercise | A | 19.54 | 23,500 | 459,190 | 23,500 | |
Jun 11 2019 | GOSS | Gossamer Bio, Inc. | GALA RENEE D | Director | Option Exercise | A | 19.54 | 23,500 | 459,190 | 23,500 | |
Jun 11 2019 | GOSS | Gossamer Bio, Inc. | Daniel Thomas O | Director | Option Exercise | A | 19.54 | 23,500 | 459,190 | 23,500 | |
Jun 11 2019 | GOSS | Gossamer Bio, Inc. | Cox Russell J. | Director | Option Exercise | A | 19.54 | 23,500 | 459,190 | 23,500 | |
Jun 11 2019 | GOSS | Gossamer Bio, Inc. | Burow Kristina | Director | Option Exercise | A | 19.54 | 23,500 | 459,190 | 23,500 | |
Jun 11 2019 | GOSS | Gossamer Bio, Inc. | Bilenker Joshua H. | Director | Option Exercise | A | 19.54 | 23,500 | 459,190 | 23,500 | |
Jun 03 2019 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Buy | P | 18.70 | 1,000 | 18,700 | 1,000 | 0 to 1,000 |
Mar 26 2019 | GOSS | Gossamer Bio, Inc. | Dupont Jakob | Chief Medical Offic ... | Option Exercise | A | 22.10 | 65,000 | 1,436,500 | 65,000 | |
Mar 26 2019 | GOSS | Gossamer Bio, Inc. | Salter-Cid Luisa | Chief Scientific Of ... | Option Exercise | A | 22.10 | 120,000 | 2,652,000 | 120,000 | |
Mar 26 2019 | GOSS | Gossamer Bio, Inc. | Christian Waage | EVP & General Couns ... | Option Exercise | A | 22.10 | 105,000 | 2,320,500 | 105,000 | |
Mar 26 2019 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Option Exercise | A | 22.10 | 145,000 | 3,204,500 | 145,000 | |
Mar 26 2019 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Option Exercise | A | 22.10 | 380,000 | 8,398,000 | 380,000 | |
Mar 26 2019 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Executive Chairman | Option Exercise | A | 22.10 | 43,500 | 961,350 | 43,500 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,554,388 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,554,388 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 16,571,428 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | Option Exercise | C | 0.00 | 16,571,429 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | Buy | C | 0.00 | 345,419 | 0 | 4,027,958 | 3.7 M to 4 M (+9.38 %) |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | Buy | C | 0.00 | 3,682,539 | 0 | 3,682,539 | 0 to 3.7 M |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | Buy | C | 0.00 | 345,419 | 0 | 4,027,958 | 3.7 M to 4 M (+9.38 %) |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | ARCH Venture Partners IX, LLC | 10% Owner | Buy | C | 0.00 | 3,682,539 | 0 | 3,682,539 | 0 to 3.7 M |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Omega Fund V, L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,165,760 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Omega Fund V, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,124,620 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Omega Fund V, L.P. | 10% Owner | Option Exercise | C | 0.00 | 20,000,000 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Omega Fund V, L.P. | 10% Owner | Buy | C | 0.00 | 6,953,416 | 0 | 6,953,416 | 0 to 7 M |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Burow Kristina | Director | Option Exercise | C | 0.00 | 1,554,388 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Burow Kristina | Director | Option Exercise | C | 0.00 | 1,554,388 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Burow Kristina | Director | Option Exercise | C | 0.00 | 16,571,428 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Burow Kristina | Director | Option Exercise | C | 0.00 | 16,571,429 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Burow Kristina | Director | Buy | C | 0.00 | 345,419 | 0 | 4,027,958 | 3.7 M to 4 M (+9.38 %) |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Burow Kristina | Director | Buy | C | 0.00 | 3,682,539 | 0 | 3,682,539 | 0 to 3.7 M |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Burow Kristina | Director | Buy | C | 0.00 | 345,419 | 0 | 4,027,958 | 3.7 M to 4 M (+9.38 %) |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Burow Kristina | Director | Buy | C | 0.00 | 3,682,539 | 0 | 3,682,539 | 0 to 3.7 M |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Cox Russell J. | Director | Buy | P | 16.00 | 7,200 | 115,200 | 7,200 | 0 to 7.2 K |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Daniel Thomas O | Director | Option Exercise | C | 0.00 | 171,429 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Daniel Thomas O | Director | Buy | C | 0.00 | 38,095 | 0 | 38,095 | 0 to 38.1 K |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Christian Waage | EVP & General Couns ... | Option Exercise | C | 0.00 | 15,543 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Christian Waage | EVP & General Couns ... | Buy | P | 16.00 | 1,550 | 24,800 | 501,498 | 499.9 K to 501.5 K (+0.31 %) |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Christian Waage | EVP & General Couns ... | Buy | C | 0.00 | 3,454 | 0 | 3,454 | 0 to 3.5 K |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Option Exercise | C | 0.00 | 23,316 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Option Exercise | C | 0.00 | 57,142 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Buy | P | 16.00 | 6,000 | 96,000 | 23,879 | 17.9 K to 23.9 K (+33.56 %) |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Buy | C | 0.00 | 17,879 | 0 | 17,879 | 0 to 17.9 K |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Option Exercise | C | 0.00 | 55,957 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Option Exercise | C | 0.00 | 223,182 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Gujrathi Sheila | President & CEO | Buy | C | 0.00 | 62,030 | 0 | 4,038,242 | 4 M to 4 M (+1.56 %) |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Executive Chairman | Option Exercise | C | 0.00 | 77,719 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Executive Chairman | Option Exercise | C | 0.00 | 185,984 | 0 | 0 | |
Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Executive Chairman | Buy | C | 0.00 | 58,599 | 0 | 3,372,109 | 3.3 M to 3.4 M (+1.77 %) |
Page: 1